Notable players in the medical styrenic block copolymers market are :
Kraton Corporation
TSRC Corporation
China Petroleum & Chemical Corporation
LG Chem
Dynasol Group
Asahi Kasei Corporation
Kumho Petrochemical
LCY Chemical Corp
INEOS Styrolution Group GmbH
JSR Corporation
RTP Company
Zeon Corporation
En Chuan Chemical Industries Co., Ltd
Trinseo SA
Authors:
Kiran Pulidindi, Kunal Ahuja
Frequently Asked Questions (FAQ) :
Global medical SBC market was worth over USD 600 million in 2022 and is predicted to exhibit more than 7% CAGR from 2023 to 2032 due to a considerable rise in demand for respiratory devices, oxygen masks, and other medical equipment escalated by rising healthcare concerns.
The Styrene Ethylene Butylene Styrene (SEBS) segment is poised to garner over USD 450 million by 2032 driven by the increasing utilization of SEBS in manufacturing several medical devices and equipment such as comprising tourniquets, surgical covers, blood separators, infusion tubes, rubber stoppers, etc.
The North America medical SBC market is poised to be valued at over USD 500 million by 2032 owing to the strong competitive landscape and rapid transition toward SBC-based medical equipment.
Prominent enterprises in the medical Styrenic block copolymers market are Kraton Corporation, TSRC Corporation, China Petroleum & Chemical Corporation, LG Chem, Dynasol Group, Asahi Kasei Corporation, Kumho Petrochemical, LCY Chemical Corp, INEOS Styrolution Group GmbH, JSR Corporation, RTP Company, Zeon Corporation, En Chuan Chemical Industries Co., Ltd., and Trinseo SA.